Peter Dolan steps down.
Wednesday, September 13th, 2006Peter Dolan, head of US pharmaceuticals giant Bristol-Myers Squibb, has stepped down over a botched deal to block the sale of a generic version of it’s bestselling Plavix. Investors cheered on this news as the company’s stock rose 3 percent to USD 24.05 by lunchtime trading on Tuesday ( 12th September 2006 ).
Plavix, a drug [...]